ArticleBMC cancer2020

A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol.

Lin-Rui Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.